Evidence map›Paper›PMID 41862735›Full record

ReviewApplied microbiology and biotechnology2026

Insights into the antimicrobial and antibiofilm activities of ionic liquids and their mechanisms of action.

Hadeer M Bedair, Israa A Elmasry, Fotouh R Mansour

Abstract readReview
In one paragraph

Review in Applied microbiology and biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Bioactive Sulfated Polysaccharides from Green AlgaeInternational journal of molecular sciences · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Hadeer M BedairDepartment of Microbiology and Immunology, College of Pharmaceutical Sciences and Drug Manufacturing, Misr University for Science and Technology, the 6Th of October City, 12566, Egypt.ORCID http://orcid.org/0000-0002-4263-0575
Israa A ElmasryDepartment of Microbiology and Immunology, College of Pharmaceutical Sciences and Drug Manufacturing, Misr University for Science and Technology, the 6Th of October City, 12566, Egypt.ORCID http://orcid.org/0000-0002-7610-6704
Fotouh R MansourPharmaceutical Analytical Chemistry Department, Faculty of Pharmacy, Tanta University, Tanta, 31111, Egypt. fotouhrashed@pharm.tanta.edu.eg.ORCID http://orcid.org/0000-0003-0847-4035

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The need for novel antibacterial and antifungal treatments originates from the growing incidence of multidrug-resistant organisms, which is a serious public health concern. Conventional antibacterial and antifungal drugs are restricted by their narrow activity spectrum and lack of appropriate targets. The rise of antifungal drug resistance has made numerous commonly used drug classes ineffective, greatly complicating the clinical treatment of fungal infections. Additionally, bacteria and fungi that form biofilms are considered a major public health issue because they evade host defenses and contribute to antimicrobial resistance. To overcome these challenges, novel alternatives such as ionic liquids (ILs) have been developed. These compounds exhibit antifungal and antibacterial properties and can additionally function as antibiofilm agents. This review explores the nature of these materials, their methods of preparation, their uses, and their advantages. Furthermore, the antimicrobial activities of various ILs toward Gram-positive bacteria, Gram-negative one, and fungal species (spp) are discussed. Additionally, different mechanisms of action of these materials, along with their antibiofilm activity, will be discussed in this review.

Indexed as

Anti-Bacterial AgentsAntifungal AgentsAnti-Infective AgentsBiofilmsFungiIonic LiquidsBacteriaGram-Negative BacteriaGram-Positive BacteriaAnti-Bacterial AgentsAntifungal AgentsAnti-Infective AgentsIonic LiquidsAntibacterial resistanceAntibiofilmAntifungal resistanceIonic liquidsMechanism of action

Identifiers

PMID41862735
PMCPMC13005822

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.